StockWatch
·
Surgical & Medical Instruments & Apparatus
Quarterly ResultMay 20, 2026, 05:18 PM

Global Innovative Platforms Reports First Revenue of $106.5K; Cash Up to $327K

AI Summary

Global Innovative Platforms Inc. reported its first revenue of $106,500 for the three months ended March 31, 2026, and $136,500 for the six months, primarily from an agreement involving its VOCAM Plus diagnostic technology. The company significantly increased its cash and cash equivalents to $327,270 and reduced its net cash used in operating activities. Despite this progress, the company continues to operate at a net loss and its financial statements include a "going concern" explanatory paragraph.

Key Highlights

  • Global Innovative Platforms reported first revenue of $106,500 for Q1 2026, and $136,500 for the six months ended March 31, 2026.
  • Cash and cash equivalents increased to $327,270 as of March 31, 2026, from $17,828 in September 2025.
  • Net loss per common share improved to $(0.003) for Q1 2026 from $(0.004) in Q1 2025.
  • Net cash used in operating activities reduced to $(136,797) for the six months, from $(311,606) YoY.
  • Total assets increased to $591,958 as of March 31, 2026, from $199,275 in September 2025.
  • Capitalized product development costs as a fixed asset in October 2025, now valued at $221,606.
  • Issued 717,000 equity shares for services in Q1 2026, including 250,000 shares to the CEO.
  • Subsequent to quarter-end, sold 422,584 shares for $105,646 in April 2026.